Global
Transfection
Technologies Market Research Report By Transfection Method (Cotransfection,
Electroporation, Cationic Lipid Transfection, In Vivo Transfection), By
Applications (Virus production, Protein production, Gene silencing, Stem cell
reprogramming & differentiation, Stable cell line generation), Geography
(North America, South America, Europe, Asia-Pacific, Middle East and Africa) –
Industry Trends and Forecast to 2026
Some
of the major market competitors currently working in the global Transfection
technologies market are Lonza., Promega Corporation., Sigma-Aldrich Co. ,
Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc. , Roche Molecular
Systems, Inc., QIAGEN, Inovio Pharmaceuticals, Inc., POLYPLUS TRANSFECTION,
Mirus Bio LLC, Takara Bio Inc., SignaGen Laboratories, MaxCyte, Inc., Genlantis
Inc., Techulon, BioAstrum Corporation., Altogen Biosystems, OZ Biosciences,
Boca Scientific, Inc., Biontex Laboratories GmbH. , and others.
Get Sample Copy
of Research Report @ www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transfection-technologies-market
Global
transfection technologies market is registering a substantial CAGR of 9.74% in
the forecast period of 2019-2026. This rise in the market can be attributed to
surge in research & development in the field of cell based therapies and
massive funds by government and private players.
Market Definition:
Transfection
is an approach to produce exogenous nucleic acids such as DNA, RNA or
oligonucleotide into cells. Such nucleic acids can be transferred by polymeric
or lipid transfection reagents which promote the cellular absorption. This
method is widely used for genomic studies (cell representation, testing, RNA
interference, in vitro research) but can be conducted for bio-production
(vaccine and protein manufacturing) or medicinal reasons (animal cell
treatment). Nucleic acid delivery to cells can be accomplished by distinct
physical techniques, such as electroporation, sonoporation or microinjection;
however, these procedures are comparatively hazardous to cells. Transfection
with chemical substances is a better option for maintaining healthy cell
feasibility.
Market Drivers
- Surge in research
& development in the field of cell based therapies is contributing to the
growth of the market - Massive funds by
government and private players is boosting the growth of the market - Growing occurrences of
cancer diseases is propelling the growth of the market - Increasing number of
obese and overweight population is driving the growth of the market
Market Restraints
- Cost of transfection
technology instruments is hampering the growth of the market - Hazard of negative
reaction with the cell is hindering the growth of the market - Home brew reagents
restricts sale of business supply which is restricting the growth of the market
View Full TOC @ www.databridgemarketresearch.com/toc/?dbmr=global-transfection-technologies-market
Segmentation:
By Transfection Method
- Cotransfection
- Electroporation
- Cationic Lipid
Transfection - In Vivo
Transfection
By Applications
- Virus Production
- Protein
Production - Gene Silencing
- Stem Cell
Reprogramming & Differentiation - Stable Cell Line
Generation
By Geography
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Rest of Middle East & Africa
Key Developments in the Market:
- In December 2018,
Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection
reagent for medical and industrial lentivirus and adeno-associated disease
(AAV) tissue & DNA therapy. This reagent was launched to promote the
medical stage and the commercialization stage of manufacturing. - In May 2018, Altogen
Biosystems released a new version of AltoFect, a second generation transfection
reagent for the hard-to-transfect cell lines to primary cell types. AltoFect
transfection reagent appears to have up to 85 percent efficiency of
transfection in difficult-to-transfect cells, like B-cells, T-cells and primary
cell cultures. This reagent allows scientists to solve difficulties and
constraints linked to primary cells and difficult-to-transfect cell lines.
Competitive Analysis:
Global
Transfection technologies market is highly fragmented and the major players
have used various strategies such as new product launches, expansions,
agreements, joint ventures, partnerships, acquisitions, and others to increase
their footprints in this market. The report includes market shares of
Transfection technologies market for global, Europe, North America,
Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
- Current and future of
global transfection technologies market outlook in the developed and emerging
markets - The segment that is
expected to dominate the market as well as the segment which holds highest CAGR
in the forecast period - Regions/Countries that
are expected to witness the fastest growth rates during the forecast period - The latest
developments, market shares, and strategies that are employed by the major
market players
Customization of the Report:
- All segmentation
provided above in this report is represented at country level - All products covered
in the market, product volume and average selling prices will be included as
customizable options which may incur no or minimal additional cost (depends on
customization)
Enquire for further
detailed information before the purchase of this research report @ www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-transfection-technologies-market
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today!
Data Bridge set forth itself as an unconventional
and neoteric Market research and consulting firm with an unparalleled level of
resilience and integrated approaches. We are determined to unearth the best
market opportunities and foster efficient information for your business to
thrive in the market. Data Bridge endeavors to provide appropriate solutions to
complex business challenges and initiates an effortless decision-making
process. Data Bridge is an aftermath of sheer wisdom and experience which was
formulated and framed in the year 2015 in Pune.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: [email protected]